Clinical Trial Update: Long-Term Effects of Iodine I Tositumomab and Autologous Bone Marrow or Stem Cell Transplantation in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

View source ↗

Summary

This clinical trial update reports the long-term effects of combining Iodine-131 labeled tositumomab with autologous bone marrow or stem cell transplantation in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Bexxar (tositumomab)
• Iodine-131 (Iodine-131)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Lymphoma, Quality of Life | Status: COMPLETED